Jen-Hong Lan
Papers
1
Total Citations
4
H-Index
1
About
Dr. Jen-Hong Lan is a leading expert in stereotactic radiosurgery and radiation oncology physics, with a focused research portfolio on treatment planning optimization and secondary cancer risk assessment. His most cited work, a 2019 study on the CyberKnife M6 robotic radiosurgery system, critically compared plan quality and secondary malignancy risks between multileaf collimator (MLC)-based and IRIS collimator-based plans for benign intracranial lesions. This investigation provided pivotal clinical evidence that MLC-based plans can achieve superior dose conformity and organ-at-risk sparing, thereby potentially reducing the long-term carcinogenic impact of radiosurgery. Dr. Lan’s contributions directly inform safer, more effective treatment protocols for patients with non-malignant brain tumors, balancing curative intent with late-effect minimization. Though his citation count is currently modest, his work represents a foundational step in personalized radiosurgery planning—a domain with growing relevance as robotic systems become more prevalent. By bridging dosimetric physics and clinical oncology, Dr. Lan continues to shape how radiation oncologists evaluate and mitigate treatment-induced secondary cancers, making his research essential for practitioners committed to lifelong patient safety.
Research Focus
Key Achievements
Top Papers
- 1